BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 28247215)

  • 1. First-line screening tests for Cushing's syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS.
    Ceccato F; Antonelli G; Frigo AC; Regazzo D; Plebani M; Boscaro M; Scaroni C
    J Endocrinol Invest; 2017 Jul; 40(7):753-760. PubMed ID: 28247215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening Tests for Cushing's Syndrome: Urinary Free Cortisol Role Measured by LC-MS/MS.
    Ceccato F; Barbot M; Zilio M; Frigo AC; Albiger N; Camozzi V; Antonelli G; Plebani M; Mantero F; Boscaro M; Scaroni C
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3856-61. PubMed ID: 26274344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cushing's Syndrome: Screening and Diagnosis.
    Ceccato F; Boscaro M
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):209-15. PubMed ID: 27160717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic accuracy of increased late night salivary cortisol for Cushing's syndrome: a real-life prospective study.
    Ceccato F; Marcelli G; Martino M; Concettoni C; Brugia M; Trementino L; Michetti G; Arnaldi G
    J Endocrinol Invest; 2019 Mar; 42(3):327-335. PubMed ID: 29987756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation.
    Ceccato F; Artusi C; Barbot M; Lizzul L; Pinelli S; Costantini G; Niero S; Antonelli G; Plebani M; Scaroni C
    J Endocrinol Invest; 2020 Aug; 43(8):1105-1113. PubMed ID: 32060745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma.
    Ceccato F; Barbot M; Albiger N; Antonelli G; Zilio M; Todeschini M; Regazzo D; Plebani M; Lacognata C; Iacobone M; Mantero F; Boscaro M; Scaroni C
    Endocrine; 2018 Mar; 59(3):510-519. PubMed ID: 28956262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for Cushing's syndrome in obese women with and without polycystic ovary syndrome.
    Putignano P; Bertolini M; Losa M; Cavagnini F
    J Endocrinol Invest; 2003 Jun; 26(6):539-44. PubMed ID: 12952368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry in the diagnosis of subclinical hypercortisolism.
    Palmieri S; Morelli V; Polledri E; Fustinoni S; Mercadante R; Olgiati L; Eller Vainicher C; Cairoli E; Zhukouskaya VV; Beck-Peccoz P; Chiodini I
    Eur J Endocrinol; 2013 Mar; 168(3):289-96. PubMed ID: 23211572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of LC-MS/MS and immunoassay based 24-h urine free cortisol in the diagnosis of Cushing's syndrome.
    Oßwald A; Wang R; Beuschlein F; Hartmann MF; Wudy SA; Bidlingmaier M; Zopp S; Reincke M; Ritzel K
    J Steroid Biochem Mol Biol; 2019 Jun; 190():193-197. PubMed ID: 30959155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical Cushing's syndrome in adrenal incidentaloma.
    Terzolo M; Osella G; Alì A; Borretta G; Cesario F; Paccotti P; Angeli A
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):89-97. PubMed ID: 9509073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test.
    Ueland GÅ; Methlie P; Kellmann R; Bjørgaas M; Åsvold BO; Thorstensen K; Kelp O; Thordarson HB; Mellgren G; Løvås K; Husebye ES
    Eur J Endocrinol; 2017 Jun; 176(6):705-713. PubMed ID: 28298353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 10:00-11:00 pm urine cortisol/creatinine ratio. An alternative to late-night salivary cortisol for the diagnosis of Cushing's syndrome.
    Bruno OD; Rossi MA; Juárez-Allen L; Serra HA; Albiero MC
    Medicina (B Aires); 2015; 75(6):373-8. PubMed ID: 26707659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparing overnight dexamethasone suppression test, urine free cortisol, and midnight serum cortisol for the initial diagnosis of Cushing' s syndrome].
    Tang TJ; Liu YP; Yu YR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):764-8. PubMed ID: 24325108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic value of urinary free cortisol in the subclinical Cushing's syndrome in patients with adrenal incidentaloma].
    Li LL; Zhao L; Dou JT; Yang GQ; Gu WJ; Lü ZH; Ba JM; Mu YM
    Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(46):3632-3635. PubMed ID: 29275606
    [No Abstract]   [Full Text] [Related]  

  • 15. Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas.
    Reimondo G; Allasino B; Bovio S; Saba L; Ardito A; Angeli A; Terzolo M
    J Endocrinol Invest; 2011 Jan; 34(1):e1-5. PubMed ID: 20634637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved liquid chromatography-tandem mass spectrometry method in clinical utility for the diagnosis of Cushing's syndrome.
    Fong BM; Tam S; Leung KS
    Anal Bioanal Chem; 2010 Jan; 396(2):783-90. PubMed ID: 19898997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary cortisol and cortisone in diagnosis of Cushing's syndrome - a comparison of six different analytical methods.
    Bäcklund N; Brattsand G; Lundstedt S; Aardal E; Bartuseviciene I; Berinder K; Höybye C; Burman P; Edén Engström B; Isaksson A; Blomgren A; Ragnarsson O; Rüetschi U; Wahlberg J; Olsson T; Dahlqvist P
    Clin Chem Lab Med; 2023 Sep; 61(10):1780-1791. PubMed ID: 37013440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of salivary cortisol in the diagnosis of Cushing's syndrome, adrenal incidentaloma, and adrenal insufficiency.
    Ceccato F; Barbot M; Zilio M; Ferasin S; Occhi G; Daniele A; Mazzocut S; Iacobone M; Betterle C; Mantero F; Scaroni C
    Eur J Endocrinol; 2013 Jul; 169(1):31-6. PubMed ID: 23610124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary-adrenal axis and peripheral cortisol metabolism in obese patients.
    Ceccato F; Lizzul L; Barbot M; Scaroni C
    Endocrine; 2020 Aug; 69(2):386-392. PubMed ID: 32564190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In the overnight dexamethasone suppression test, 1.0 mg loading is superior to 0.5 mg loading for diagnosing subclinical adrenal Cushing's syndrome based on plasma dexamethasone levels determined using liquid chromatography-tandem mass spectrometry.
    Sasaki Y; Katabami T; Asai S; Fukuda H; Tanaka Y
    Endocr J; 2017 Sep; 64(9):833-842. PubMed ID: 28637948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.